Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for reducing symptoms of multiple sclerosis using a six-amino acid long peptide that inhibits CD40-CD154 interaction

Methods for reducing symptoms of multiple sclerosis using a six-amino acid long peptide that inhibits CD40-CD154 interaction

US Patent 12472223 · Granted Nov 18, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapeutic peptides and methods for treating type 2 diabetes2025
Therapeutic peptides and methods for treating type 2 diabetes2025
Peptides and methods for treating disease2025
Peptides and methods for treating disease2025
Bioactive peptides and methods of use thereof2024
Bioactive peptides and methods of use thereof2024
Bioactive peptides and methods of use thereof2024
Methods for reducing symptoms of multiple sclerosis using a six-amino acid long 2023
Methods for reducing symptoms of multiple sclerosis using a six-amino acid long 2023
Methods for reducing symptoms of multiple sclerosis using a six-amino acid long 2023
Peptides and methods for treating disease2023
Peptides and methods for treating disease2023